{"id":"W1968622004","doi":"10.3109/10428194.2010.496506","title":"Ribavirin as an anti-cancer therapy: acute myeloid leukemia and beyond?","year":2010,"lang":"en","type":"review","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Biochemical and Molecular Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":144,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute for Research in Immunology and Cancer; Université de Montréal","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"Ribavirin; IMP dehydrogenase; Cancer; Medicine; Leukemia; Myeloid leukemia; EIF4E; Cancer research; Immunology; Biology; Virus; Hepatitis C virus; Internal medicine; Translation (biology); Transplantation; Mycophenolic acid; Gene; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004809613,0.000756674,0.001262395,0.001328624,0.0003075369,0.001037427,0.0007311256,0.001483753,0.003031939],"category_scores_gemma":[0.0005116128,0.000227685,0.000289633,0.001929291,0.0006907264,0.0019104,0.0005478055,0.002104586,0.003752794],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000875715,"about_ca_system_score_gemma":0.0006985508,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00103161,"about_ca_topic_score_gemma":0.001983768,"domain_scores_codex":[0.9998599,0.00003536455,0.00001540713,0.00002587928,0.00004903807,0.00001449571],"domain_scores_gemma":[0.9998391,0.00005960184,0.00001806076,0.000007738953,0.00004959663,0.00002589516],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001241839,0.00009688695,0.0001373707,0.005936882,0.00004733552,0.0003096818,0.00008260794,0.0003138919,0.003271092,0.008331875,0.04559873,0.9357494],"study_design_scores_gemma":[0.00002139027,0.00007349446,0.0003258606,0.0009164332,0.00002073168,0.0009899975,0.00003609338,0.00006150433,0.0003814563,0.002439379,0.9947236,0.00001016436],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001074729,0.9974403,0.0001181586,0.0006826542,0.0002966573,0.00000343126,0.00000824798,0.000006871286,0.001336095],"genre_scores_gemma":[0.0008251476,0.9964611,0.0002057974,0.000698534,0.0002717917,0.000006965575,0.00001603145,0.000002521263,0.001512101],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003031939,"threshold_uncertainty_score":0.01014286,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0170753322536928,"score_gpt":0.3112245452087337,"score_spread":0.2941492129550409,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}